Healthcare, Regulatory and Reimbursement Landscape - Jordan

133pages

Published Date: January 2013

Published By: GlobalData

Category: Healthcare
Description

Healthcare, Regulatory and Reimbursement Landscape - Jordan

Summary

GlobalData, the industry analysis specialist, has released its new report, Healthcare, Regulatory and Reimbursement Landscape - Jordan. The report is an essential source of information and provides an analysis of the healthcare, regulatory and reimbursement landscape of Jordan. 


The report identifies the key trends in the healthcare market of Jordan. The report also provides insights on the demographic, regulatory, reimbursement landscape and healthcare infrastructure of Jordan. Most importantly, the report provides valuable insights on the trends and segmentation of the pharmaceutical market. This report is built using data and information sourced from proprietary databases, secondary research and in-house analysis by GlobalDatas team of industry experts.

Jordan has a small population, approximately 6.2 million in 2011. However, the population of Jordan is increasing due to a high birth rate and low mortality rate, along with an increase in life expectancy. The increase in the population of the working-age sector of the population will support the countrys development, but the countrys high unemployment rate is a cause of concern for policy planners. The pharmaceutical market in Jordan was estimated at $487.6m in 2011 and is expected to reach approximately $1,112.1m by 2020, at a projected Compound Annual Growth Rate (CAGR) of 9.6% between 2012 and 2020.

The positive trend in the healthcare market of Jordan can be attributed primarily to -
  • Increase in exports of pharmaceutical products
  • High share of public health insurance
  • Increasing access to healthcare facilities
  • Government initives in healthcare sector 
  • Increasing affordabilty
Scope

The report provides information on the healthcare, regulatory and reimbursement landscape of Jordan. The scope includes -
  • An overview of the pharmaceutical market of Jordan including the market size, market segmentation, key drivers and barriers for the market.
  • Profiles and SWOT analyses of the major players in the pharmaceutical market. Key players covered for the pharmaceutical market are Hikma Pharmaceuticals, Dar al Dawa Development & Investment, Jordan Pharmaceutical Manufacturing and Pharma International. 
  • An insightful review of the reimbursement and regulatory landscape. The analysis includes details of the healthcare reimbursement process, regulatory agencies and marketing authorization process for new drugs in Jordan.
  • A detailed analysis of the political and economic environment of Jordan, including the economic indicators, demographics, healthcare infrastructure and healthcare expenditure. 
  • An overview of the opportunities and challenges for growth that exist in the healthcare market of Jordan.
Reasons to buy

The report comprehensively covers pharmaceutical market of Jordan, and will enhance your decision-making capability. It will allow you to -
  • Develop business strategies by understanding the trends shaping and driving the healthcare market of Jordan. 
  • Drive revenues by understanding the key trends, reimbursement and regulatory policies, pharmaceutical market segments and companies likely to impact the Jordanian healthcare market in the future. 
  • Formulate effective sales and marketing strategies by understanding the competitive landscape and by analyzing the performance of various competitors. 
  • Organize your sales and marketing efforts by identifying the market categories and segments that present maximum opportunities for consolidations, investments and strategic partnerships. 
  • Identify, understand and capitalize on the opportunities and challenges in the healthcare market of Jordan.

 

 

Table of Contents

1 Table of Contents 5
1.1 List of Tables 6
1.2 List of Figures 7

2 Introduction 9
2.1 Report Guidance 9

3 Overview of the Pharmaceutical and Medical Devices Market 10
3.1 Pharmaceutical Market 10
3.1.1 Market Overview 10
3.1.2 Supply Channels 13
3.1.3 Market Segments 14
3.1.4 Major Disease Areas 17
3.1.5 Major Players 18
3.2 Medical Device Market 34
3.2.1 Market Overview 34
3.3 Market Drivers and Barriers 35
3.3.1 Drivers 35
3.3.2 Barriers 36

4 Market Access 38
4.1 Reimbursement and Payer Landscape 38
4.1.1 Healthcare System Overview 38
4.1.2 Reimbursement Process 38
4.1.3 Overview of Insurance Providers 41
4.1.4 Patients Share in Healthcare Spending 42
4.1.5 Price Trend in Healthcare Services 43
4.1.6 Pricing Policies 43
4.2 Regulatory Landscape 45
4.2.1 Overview of Regulatory Agencies 45
4.2.2 Marketing Authorization Procedure for Pharmaceutical Products 45
4.2.3 Licensing Process for Pharmaceutical and Medical Device Manufacturing 47
4.2.4 Licensing Process for Pharmaceutical Exports and Imports 49
4.2.5 Intellectual Property Rights 50
4.2.6 Clinical Trial Regulations 55
4.2.7 Pharmaceutical Advertising Regulations 55
4.2.8 Pharmacy Regulations 56
4.2.9 Labeling and Packaging Regulations 56

5 Country Analysis 58
5.1 Political Environment 58
5.1.1 Political Structure 58
5.1.2 Analysis of the Current Political Environment 59
5.1.3 Healthcare Policy Initiatives 60
5.2 Economic Landscape 61
5.3 Economic Indicators 63
5.3.1 Gross Domestic Product 63
5.3.2 Gross National Income 67
5.3.3 Inflation 68
5.3.4 Currency Exchange Rate 71
5.3.5 Foreign Direct Investment 72
5.3.6 Foreign Exchange Reserves 73
5.3.7 Trade Balance 74
5.3.8 Government Net Debt 76
5.3.9 Government Structural Balance 78
5.3.10 Major Industries 80
5.4 Demography 81
5.4.1 Population 81
5.4.2 Education and Literacy 96
5.4.3 Employment 98
5.4.4 Disease Burden 100
5.5 Healthcare Infrastructure 101
5.5.1 Healthcare Facilities 101
5.5.2 Healthcare Parameters 108
5.5.3 Environmental Health 110
5.5.4 Healthcare Personnel 116
5.6 Healthcare Expenditure 117
5.6.1 Overview 117
5.6.2 Major Components of Healthcare Spending 118
5.6.3 Share of Public and Private Sectors 119
5.6.4 Spending in Healthcare R&D 119
5.7 Trade Associations 119
5.7.1 Jordanian Association of Pharmaceutical Manufacturers 119
5.7.2 Jordan Pharmacist Association 119

6 Opportunities and Challenges 120
6.1 Opportunities 120
6.2 Challenges 121

7 Appendix 123
7.1 Abbreviations 123
7.2 Bibliography 124
7.3 Methodology 131
7.3.1 Coverage 131
7.3.2 Secondary Research 132
7.3.3 Forecasting 132
7.3.4 Primary Research 132
7.3.5 Expert Panel Validation 132
7.4 Contact Us 133
7.5 Disclaimer 133


List Of Figures


Figure 1: Pharmaceutical Market, Jordan, Revenue ($m), 2006-2011
Figure 2: Pharmaceutical Market, Jordan, Forecast ($m), 2012-2020
Figure 3: Pharmaceutical Distribution Process, Ministry of Health, Jordan, 2012
Figure 4: Pharmaceutical Distribution Process, Private Sector, Jordan, 2012
Figure 5: Drivers and Barriers, Healthcare Market, Jordan, 2012
Figure 6: Addition of Drug in JNDF, Jordan, 2012
Figure 7: Healthcare Spending, Jordan, Patient's Share (%), 2005-2010
Figure 8: Price Trend in Healthcare Sector (%), Jordan, 2005-2010
Figure 9: Marketing Authorization Procedure, Jordan, 2012
Figure 10: Licensing Process for Pharmaceutical Manufacturing, Jordan, 2012
Figure 11: Patent Approval Process, Jordan, 2012
Figure 12: Trademark Approval Process, Jordan, 2012
Figure 13: GDP Per Capita ($), Jordan, 2006-2011
Figure 14: GDP Per Capita ($), Jordan, Forecast, 2012-2020
Figure 15: GDP, Jordan, Annual Growth (%), 2006-2011
Figure 16: GDP, Jordan, Annual Growth (%), Forecast, 2012-2020
Figure 17: GNI Per Capita ($), Jordan, 2006-2011
Figure 18: Average Consumer Price Index, Jordan, 2006-2011
Figure 19: Average Consumer Price Index, Jordan, Forecast, 2012-2020
Figure 20: Average Consumer Price, Jordan, Annual Change (%), 2006-2011
Figure 21: Average Consumer Price, Jordan, Annual Change (%), Forecast, 2012-2020
Figure 22: Currency Exchange Rate ($/JOD), Jordan, 2006-2011
Figure 23: Foreign Direct Investment ($bn), Jordan, 2005-2010
Figure 24: Foreign Exchange Reserves ($bn), Jordan, 2006-2011
Figure 25: Imports of Goods and Services ($bn), Jordan, 2006-2011
Figure 26: Exports of Goods and Services ($bn), Jordan, 2006-2011
Figure 27: General Government Net Debt ($bn), Jordan, 2006-2011
Figure 28: General Government Net Debt ($bn), Jordan, Forecast, 2012-2020
Figure 29: General Government Structural Balance ($bn), Jordan, 2006-2011
Figure 30: General Government Structural Balance ($bn), Jordan, Forecast, 2012-2020
Figure 31: Major Industries, Jordan, GDP ($bn), 2011
Figure 32: Population (m), Jordan, 2006-2011
Figure 33: Population (m), Jordan, Forecast, 2012-2020
Figure 34: Urban and Rural Population, Jordan, Share (%), 2006-2011
Figure 35: Age Groups, Jordan, Population Distribution (%), 2006-2011
Figure 36: Age Groups, Jordan, Population Distribution (%), Forecast, 2012-2020
Figure 37: Births (Per 1,000 Population), Jordan, 2006-2011
Figure 38: Mortality (Per 1,000 Population), Jordan, 2006-2011
Figure 39: Major Causes of Mortality (‘000s), Jordan, 2008
Figure 40: Children <5 Years Age, Jordan, Mortality (Per 1,000 Live Births), 2005-2010
Figure 41: Maternal Mortality (Per 100,000 Live Births), Jordan, 2006-2011
Figure 42: Immunization Rate (%), Jordan, 2006-2011
Figure 43: Major Causes of Male Mortality (‘000s), Jordan, 2008
Figure 44: Major Causes of Female Mortality (‘000s), Jordan, 2008
Figure 45: Gender Ratio (Male Per 100 Female Population), Jordan, 2006-2011
Figure 46: Life Expectancy at Birth (Years), Jordan, 2006-2011
Figure 47: Illiteracy Rate, Jordan, Population (%), 2006-2011
Figure 48: Levels of Education, Jordan, Students Share (%), 2006-2011
Figure 49: Unemployment Rate (%), Jordan, 2006-2011
Figure 50: Employees, Jordan, Segment Share (%), 2011
Figure 51: Major Diseases, Jordan, DALY (Per 100,000 Population), 2004
Figure 52: Hospitals, Jordan, 2006-2011
Figure 53: Public and Private Hospitals, Jordan, 2006-2011
Figure 54: Public Hospitals by Ownership, Jordan, 2006-2011
Figure 55: MoH Health Centers, Jordan, 2006-2011
Figure 56: Hospital by Standard of Care, Jordan, Share (%), 2010
Figure 57: Diagnostic Facilities, Jordan, Diagnostic Devices (Per 100,000 Population), 2010
Figure 58: Hospital Beds (Per 1,000 Population), Jordan, 2006-2011
Figure 59: Physicians (Per 1,000 Population), Jordan, 2006-2011
Figure 60: Environmental Attributable Deaths (Per 100,000 Population), Jordan, 2004
Figure 61: PM10 (µg/m3), Jordan, 2005-2010
Figure 62: CO2 Emissions (Million Tons), Jordan, 2005-2010
Figure 63: Organic Water Pollutant Emissions (Metric Tons per Day), Jordan, 2005-2010
Figure 64: Waste Generation (Million Tons), Jordan, 2005-2010
Figure 65: Healthcare Personnel (Per 10,000 Population), Jordan, 2006-2011
Figure 66: Healthcare Expenditure (Percentage of the GDP), Jordan, 2005-2010
Figure 67: Public Healthcare Expenditure, Jordan, Share of Major Components (%), 2007
Figure 68: Healthcare Expenditure, Jordan, Public-Private Share (%), 2005-2010
Figure 69: Opportunities and Challenges, Healthcare Market, Jordan, 2012


List Of Tables


Table 1: Pharmaceutical Market, Jordan, Revenue ($m), 2006-2011 11
Table 2: Pharmaceutical Market, Jordan, Forecast ($m), 2012-2020 12
Table 3: Drugs Going Off-patent, Revenues ($bn), Global, 2011-2015 15
Table 4: Major Products, Hikma Pharmaceuticals PLC, 2012 18
Table 5: Major Products, Dar Al Dawa Development & Investment Co. Ltd, Jordan, 2012 22
Table 6: Major Products, Jordanian Pharmaceutical Manufacturing Co. Plc, Jordan, 2012 27
Table 7: Major Products, Pharma International Co, 2012 32
Table 8: Healthcare Spending, Jordan, Patient's Share (%), 2005-2010 42
Table 9: Price Trend in Healthcare Sector (%), Jordan, 2005-2010 43
Table 10: GDP Per Capita ($), Jordan, 2006-2011 63
Table 11: GDP Per Capita ($), Jordan, Forecast, 2012-2020 64
Table 12: GDP, Jordan, Annual Growth (%), 2006-2011 65
Table 13: GDP, Jordan, Annual Growth (%), Forecast, 2012-2020 66
Table 14: GNI Per Capita ($), Jordan, 2006-2011 67
Table 15: Average Consumer Price Index, Jordan, 2006-2011 68
Table 16: Average Consumer Price Index, Jordan, Forecast, 2012-2020 69
Table 17: Average Consumer Price, Jordan, Annual Change (%), 2006-2011 70
Table 18: Average Consumer Price, Jordan, Annual Change (%), Forecast, 2012-2020 70
Table 19: Currency Exchange Rate ($/JOD), Jordan, 2006-2011 71
Table 20: Foreign Direct Investment ($bn), Jordan, 2005-2010 72
Table 21: Foreign Exchange Reserves ($bn), Jordan, 2006-2011 73
Table 22: Imports of Goods and Services ($bn), Jordan, 2006-2011 74
Table 23: Exports of Goods and Services ($bn), Jordan, 2006-2011 75
Table 24: General Government Net Debt ($bn), Jordan, 2006-2011 76
Table 25: General Government Net Debt ($bn), Jordan, Forecast, 2012-2020 77
Table 26: General Government Structural Balance ($bn), Jordan, 2006-2011 78
Table 27: General Government Structural Balance ($bn), Jordan, Forecast, 2012-2020 79
Table 28: Major Industries, Jordan, GDP ($bn), 2011 80
Table 29: Population (m), Jordan, 2006-2011 81
Table 30: Population (m), Jordan, Forecast, 2012-2020 82
Table 31: Urban and Rural Population, Jordan, Share (%), 2006-2011 83
Table 32: Age Groups, Jordan, Population Distribution (%), 2006-2011 84
Table 33: Age Groups, Jordan, Population Distribution (%), Forecast, 2012-2020 85
Table 34: Births (Per 1,000 Population), Jordan, 2006-2011 86
Table 35: Mortality (Per 1,000 Population), Jordan, 2006-2011 87
Table 36: Major Causes of Mortality (000s), Jordan, 2008 88
Table 37: Children <5 Years Age, Jordan, Mortality (Per 1,000 Live Births), 2005-2010 89
Table 38: Maternal Mortality (Per 100,000 Live Births), Jordan, 2006-2011 90
Table 39: Immunization Rate (%), Jordan, 2006-2011 91
Table 40: Major Causes of Male Mortality (000s), Jordan, 2008 92
Table 41: Major Causes of Female Mortality (000s), Jordan, 2008 93
Table 42: Gender Ratio (Male Per 100 Female Population), Jordan, 2006-2011 94
Table 43: Life Expectancy at Birth (Years), Jordan, 2006-2011 95
Table 44: Illiteracy Rate, Jordan, Population (%), 2006-2011 96
Table 45: Levels of Education, Jordan, Students Share (%), 2006-2011 97
Table 46: Unemployment Rate (%), Jordan, 2006-2011 98
Table 47: Employees, Jordan, Segment Share (%), 2011 99
Table 48: Major Diseases, Jordan, DALY (Per 100,000 Population), 2004 100
Table 49: Hospitals, Jordan, 2006-2011 102
Table 50: Public and Private Hospitals, Jordan, 2006-2011 103
Table 51: Public Hospitals by Ownership, Jordan, 2006-2011 104
Table 52: MoH Health Centers, Jordan, 2006-2011 105
Table 53: Hospital by Standard of Care, Jordan, Share (%), 2010 106
Table 54: Diagnostic Facilities, Jordan, Diagnostic Devices (Per 100,000 Population), 2010 107
Table 55: Hospital Beds (Per 1,000 Population), Jordan, 2006-2011 108
Table 56: Physicians (Per 1,000 Population), Jordan, 2006-2011 109
Table 57: Environmental Attributable Deaths (Per 100,000 Population), Jordan, 2004 110
Table 58: PM10 (g/m3), Jordan, 2005-2010 111
Table 59: CO2 Emissions (Million Tons), Jordan, 2005-2010 113
Table 60: Organic Water Pollutant Emissions (Metric Tons per Day), Jordan, 2005-2010 114
Table 61: Waste Generation (Million Tons), Jordan, 2005-2010 115
Table 62: Healthcare Personnel (Per 10,000 Population), Jordan, 2006-2011 116
Table 63: Healthcare Expenditure (Percentage of the GDP), Jordan, 2005-2010 117
Table 64: Public Healthcare Expenditure, Jordan, Share of Major Components (%), 2007 118
Table 65: Healthcare Expenditure, Jordan, Public-Private Share (%), 2005-2010 119

More Reports in





» South Africa Power Market Outlook to 2030, Update 2014 - Market Trends, Regulations and Competitive Landscape

South Africa Power Market Outlook to 2030, Update 2014 - Market Trends, Regulations and Competitive Landscape Summary This report elaborates South Africa's power market structure and provides historical and forecast numbers for generation, capacity and consumption up to 2030. Detailed analysis of South Africa power markets regulatory structure...


» Capacity and Capital Expenditure Outlook for Refineries in Africa - Nigeria to Drive Refinery Capacity Growth

Capacity and Capital Expenditure Outlook for Refineries in Africa - Nigeria to Drive Refinery Capacity Growth Summary GlobalDatas energy offering, Capacity and Capital Expenditure Outlook for Refineries in Africa - Nigeria to Drive Refinery Capacity Growth is the essential source for industry data and information relating to the refining indus...


» Capacity and Capital Expenditure Outlook for Refineries in the Middle East - Saudi Arabia and Iraq to Drive Refinery Capacity Growth

Capacity and Capital Expenditure Outlook for Refineries in the Middle East - Saudi Arabia and Iraq to Drive Refinery Capacity Growth Summary GlobalDatas energy offering, Capacity and Capital Expenditure Outlook for Refineries in the Middle East - Saudi Arabia and Iraq to Drive Refinery Capacity Growth is the essential source for industry data ...


» Ischemic Cerebral Stroke Global Clinical Trials Review, H2, 2014

Ischemic Cerebral Stroke Global Clinical Trials Review, H2, 2014 Summary GlobalData's clinical trial report, Ischemic Cerebral Stroke Global Clinical Trials Review, H2, 2014" provides data on the Ischemic Cerebral Stroke clinical trial scenario. This report provides elemental information and data relating to the clinical trials on Ischemic Cer...


» Ischemic Stroke Global Clinical Trials Review, H2, 2014

Ischemic Stroke Global Clinical Trials Review, H2, 2014 Summary GlobalData's clinical trial report, Ischemic Stroke Global Clinical Trials Review, H2, 2014" provides data on the Ischemic Stroke clinical trial scenario. This report provides elemental information and data relating to the clinical trials on Ischemic Stroke. It includes an overvie...


» Lower Limb Muscle Spasticity Global Clinical Trials Review, H2, 2014

Lower Limb Muscle Spasticity Global Clinical Trials Review, H2, 2014 Summary GlobalData's clinical trial report, Lower Limb Muscle Spasticity Global Clinical Trials Review, H2, 2014" provides data on the Lower Limb Muscle Spasticity clinical trial scenario. This report provides elemental information and data relating to the clinical trials on ...


» Lumbar Spinal Stenosis Global Clinical Trials Review, H2, 2014

Lumbar Spinal Stenosis Global Clinical Trials Review, H2, 2014 Summary GlobalData's clinical trial report, Lumbar Spinal Stenosis Global Clinical Trials Review, H2, 2014" provides data on the Lumbar Spinal Stenosis clinical trial scenario. This report provides elemental information and data relating to the clinical trials on Lumbar Spinal Sten...


» Metachromatic Leukodystrophy (MLD) Global Clinical Trials Review, H2, 2014

Metachromatic Leukodystrophy (MLD) Global Clinical Trials Review, H2, 2014 Summary GlobalData's clinical trial report, Metachromatic Leukodystrophy (MLD) Global Clinical Trials Review, H2, 2014" provides data on the Metachromatic Leukodystrophy (MLD) clinical trial scenario. This report provides elemental information and data relating to the c...


» Mania Global Clinical Trials Review, H2, 2014

Mania Global Clinical Trials Review, H2, 2014 Summary GlobalData's clinical trial report, Mania Global Clinical Trials Review, H2, 2014" provides data on the Mania clinical trial scenario. This report provides elemental information and data relating to the clinical trials on Mania. It includes an overview of the trial numbers and their recruit...


» Multiple Sclerosis Global Clinical Trials Review, H2, 2014

Multiple Sclerosis Global Clinical Trials Review, H2, 2014 Summary GlobalData's clinical trial report, Multiple Sclerosis Global Clinical Trials Review, H2, 2014" provides data on the Multiple Sclerosis clinical trial scenario. This report provides elemental information and data relating to the clinical trials on Multiple Sclerosis. It include...



Related News

News Aug 10, 2012

Theranostics Imaging Offers Means of Killing Prostate Cancer Cells without Harming Other Healthy Cells

Cancer imaging experts at John Hopkins Cancer Research Center claimed that they have developed a method for finding and killing malignant cells and sparing the healthy ones. The study was conducted on human prostate cancer cells and mice. The met...

News Oct 29, 2012

The Pharmaceutical Industry And Research

In a world in economic crisis, perhaps still unpredictable consequences in terms of its magnitude and duration, we can reflect on the possible consequences of the crisis may have on the pharmaceutical industry, especially its research and develop...

News Oct 9, 2012

A Donation fund for Pharmaceutical Research

The World Health Organization is planning a Kyoto Protocol for health. States should pay research funds to fight neglected diseases worldwide. To lofty goals lacks the World Health Organization (WHO) does not: It plans with the interests ...

News Oct 10, 2012

Allergy to Cold - Symptoms, Treatment and Tips for Everyday Life

Normally enough warm clothing to defy low outdoor temperatures. Who but suffers from an allergy to cold, has much bigger problems to deal with than "just" cold hands and feet. What is an allergy to cold and how it expresses itself ? ...

News Oct 10, 2012

Healthy Grilling Pleasure

More and more people flock to the park to enjoy the sun. And the barbecue season begins slowly: Instead of greasy sausages and potato salad with mayonnaise, we give you tips for calorie conscious and healthy grilling pleasure. Tonigh...

News Oct 10, 2012

Relaxation on Holiday - but how?

Can the earned annual leave to compensate for the hard work of the rest of the year? We need regular timeouts for regeneration? The recreation research has revealed new aspects. Secured is more important than a good holiday exchange of tension an...

News Oct 10, 2012

Stress and stress that: 7.Stress and Burnout

Everyone knows states of exhaustion - if we have spent ourselves, physically sleep after a long run or mentally after an examination or a combination of both, for example, after a long day at work or when the kids are finally in bed at night...

News Oct 10, 2012

Top 10 Tips for Losing Weight

We summarize now the top 10 tips for losing weight together: They are simple and feasible for anyone who wants to lose weight healthy. A tip from the start: Sets not all weight loss tips to and steps at once, otherwise it will be too much at once...

News Oct 10, 2012

What to do about Anorexia at the Age?

Many people who care for your children at home, the problem: In old age, many people to anorexia. To overcome this, you can use various tricks. First, it helps the members with recipes that they delight to know from your childhood. Especially wit...


All Rights Reserved   Latest News   Latest Reports